GlassScriptPhysician profile
Krishna Arthur Venkatesh
NPI 1689878472
$13,992.36
in general payments reported to CMS, 2019-2025
28 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $6,554 · 2021: $5,968 · 2022: $374 · 2023: $356 · 2024: $133 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,283.94 | 2019-2021 | |
| Covidien LP | $5,915.53 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $390.78 | 2021-2025 | Bridion |
| Coloplast Corp | $329.62 | 2019-2023 | Sensura Mio, Sensura |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.15 | 2019-2023 | Trulance |
| Ethicon US, LLC | $119.54 | 2019-2025 | Echelon; Endopath |
| Braintree Laboratories, INC. | $100.89 | 2021-2023 | Suflave, Sutab |
| Baxter Healthcare | $76.43 | 2021-2023 | Seprafilm |
| Davol INC. | $70.57 | 2020-2021 | |
| Boston Scientific Corporation | $56.26 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.06 | 2020-2023 | Gattex |
| Kci USA, INC. | $52.35 | 2019-2020 | |
| Zyla Life Sciences, INC. | $49.37 | 2019-2020 | |
| Acacia Pharma INC | $48.64 | 2021-2022 | |
| Tela Bio, INC. | $45.02 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27.28 | 2021-2023 | Signia |
| Becton, Dickinson and Company | $26.81 | 2024 | Arista Ah Flexitip |
| Pacira Pharmaceuticals Incorporated | $23.60 | 2019 | |
| Solventum Corporation | $19.70 | 2024 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Conmed Corporation | $19.66 | 2020 | |
| Mimedx Group, INC. | $18.22 | 2025 | |
| Access Pro Medical, LLC | $18.08 | 2025 | Matriderm |
| Acell, INC. | $17.99 | 2020 | |
| Innovation Technologies INC | $17.52 | 2024 | Irrisept |
| Allergan, INC. | $16.18 | 2021 | |
| Axonics, INC. | $15.60 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.59 | 2025 | |
| Medela LLC | $14.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Venkatesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.